Literature DB >> 2580020

The molecular basis of the requirement for antigen processing of pigeon cytochrome c prior to T cell activation.

Z Kovac, R H Schwartz.   

Abstract

Antigen-induced activation of T lymphocytes that co-recognize Ia molecules has been shown to require an antigen-processing step by the presenting cell before T cell stimulation can occur. In this report, we demonstrate that antigen presentation of pigeon cytochrome c to an E kappa beta:E kappa alpha-restricted T cell hybridoma, 2C2, is inhibited by pretreatment of the antigen-presenting cells (APC) either with chloroquine or with fixation by paraformaldehyde. The chloroquine effect was partially reversible after 22 hr; the paraformaldehyde effect was not. In contrast, these treatments had little or no effect on the presentation of the carboxy-terminal cyanogen bromide cleavage fragment of pigeon cytochrome c, residues 81 to 104. There was at least a 50-fold greater potency of the fragment, as compared to that of the intact molecule, when paraformaldehyde-fixed APC were used. In addition, the fixed cells did not present synthetic fragments of the cytochrome c that were nonstimulatory when presented by unfixed cells. This observation showed that the loss of potency, demonstrated previously for analogs of pigeon cytochrome c with single amino acid substitutions at positions such as 99, was not a consequence of an alteration in the rate of antigen-processing. This result is consistent with our earlier hypothesis that these residues are contact amino acids with the antigen-specific T cell receptor or the Ia molecule. The major goal of these experiments was to define the molecular transition that occurred as a result of antigen processing. To achieve this end, we tested a variety of pigeon cytochrome c molecules and fragments for their ability to be presented by paraformaldehyde-fixed APC. Apocytochrome c, the denatured form of the molecule with the heme removed, could not be presented by the fixed cells, nor could the fragment 60-104, derived by acid cleavage of the tryptophan at position 59. Both molecules stimulated an IL 2 response from the T cell hybridoma when unfixed APC were utilized, demonstrating that the conditions used to prepare these two molecules did not destroy their antigenic determinant. In contrast, carboxy-terminal fragments, both native and synthetic, ranging in size from 16 to 39 amino acids, were capable of stimulating in the presence of paraformaldehyde-fixed APC. In particular, the partial-digest cyanogen bromide fragment, residues 66 to 104, was only twofold less potent than the pigeon fragment 81-104.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2580020

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Recognition of human insulin in vitro by T cells from subjects treated with animal insulins.

Authors:  L J Nell; V J Virta; J W Thomas
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

2.  The response of T cells to soluble protein antigens and fixed antigen-presenting cells.

Authors:  R Bujdoso; A J Munro
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

3.  Immunogenicity of peptides for B cells is not impaired by overlapping T-cell epitope topology.

Authors:  D P Harris; H M Vordermeier; A Arya; K Bogdan; C Moreno; J Ivanyi
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

4.  Two genetically identical antigen-presenting cell clones display heterogeneity in antigen processing.

Authors:  M T Michalek; B Benacerraf; K L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

5.  Phospholipase treatment of accessory cells that have been exposed to antigen selectively inhibits antigen-specific Ia-restricted, but not allospecific, stimulation of T lymphocytes.

Authors:  L D Falo; B Benacerraf; K L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

6.  Modulation of antigen processing and presentation by covalently linked complement C3b fragment.

Authors:  M R Jacquier-Sarlin; F M Gabert; M B Villiers; M G Colomb
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

7.  Delineation of the minimal hepatitis B surface antigen-specific B- and T-cell epitope contained within an anti-idiotype-derived pentadecapeptide.

Authors:  M Rajadhyaksha; Y Thanavala
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

8.  Modulation of nonneutralizing HIV-1 gp41 responses by an MHC-restricted TH epitope overlapping those of membrane proximal external region broadly neutralizing antibodies.

Authors:  Jinsong Zhang; S Munir Alam; Hilary Bouton-Verville; Yao Chen; Amanda Newman; Shelley Stewart; Frederick H Jaeger; David C Montefiori; S Moses Dennison; Barton F Haynes; Laurent Verkoczy
Journal:  J Immunol       Date:  2014-01-24       Impact factor: 5.422

9.  Analysis of antigen presentation by metabolically inactive accessory cells and their isolated membranes.

Authors:  L D Falo; K Sullivan; B Benacerraf; M F Mescher; K L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

10.  Isolation and characterization of two novel peptide amides originating from myelin basic protein in bovine brain.

Authors:  K Takamatsu; K Tatemoto
Journal:  Neurochem Res       Date:  1992-03       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.